First Allied Advisory Services’s Eton Pharmaceutcials ETON Stock Holding History

First Allied Advisory Services’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-36,146	Closed	-$228K	–	1284
2019 Q3	$228K	Buy	+36,146	New	+$231K	0.01%	1031

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Allied Advisory Services's ETON Position: Q4 2019 in Review

First Allied Advisory Services sold out of Eton Pharmaceutcials (ETON) in Q4 2019, closing a stake of 36,146 shares — an estimated $228K sold.

First Allied Advisory Services first reported a position in ETON in Q3 2019 and held it in 1 quarter. The position peaked at $228K in Q3 2019. 14 funds tracked by Wall St. Rank hold ETON as of Q4 2019.

First Allied Advisory Services reported no remaining Eton Pharmaceutcials position as of Q4 2019 after selling out during the quarter.
First Allied Advisory Services sold 36,146 Eton Pharmaceutcials shares in Q4 2019, an estimated $228K.
First Allied Advisory Services first reported a position in Eton Pharmaceutcials in Q3 2019 and held it in 1 quarter.
First Allied Advisory Services's Eton Pharmaceutcials position peaked at $228K in Q3 2019.
14 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q4 2019.

Based on First Allied Advisory Services's 13F filing for Q4 2019, filed 10 Feb 2020.